China approves Sinopharm vaccine for children, teenagers


Women and a child walk by a billboard calling on people to get vaccinated against Covid-19 outside a shopping mall in Beijing, capital of China, on May 24, 2021. - AP

BEIJING (China Daily/ANN): Sinopharm's Covid-19 vaccine has been approved for emergency use for young people ages 3 to 17, after early and midstage clinical trials showed it is safe and can elicit strong immune responses in the age group, the company said in a recent statement.

The approval was granted by the Joint Prevention and Control Mechanism of the State Council, which was set up to deal with the Covid-19 pandemic.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

China , covid-19 , vaccine , Sinopharm , children , teenagers , approval

   

Next In Aseanplus News

No quitting: Bollywood's Aamir Khan wants to keep acting
Taking aim at K-pop merchandise waste
Crackdown on child marriage
‘Finally on par with other big cities’
Death penalty, life sentences for murder of German man
China ‘firmly opposes’ US military aid to Taiwan
Saving endangered animals with IVF
Measles resurgence warned as 375 cases confirmed
An iconic look fading with time
Weightlifting granny garners cheers at gym

Others Also Read